Denali Therapeutics Inc. - DNLI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$3.147B

QoQ value delta ($000)

+$749M (+31.23%)

Implied price effect (QoQ)

+14.12%

Total shares

167,023,087

QoQ shares delta

+21,783,082 (+15.0%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 270 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	250,261	13,034,434	0.0%
BAILLIE GIFFORD & CO	231,676	12,066,479	0.24%
VANGUARD GROUP INC	215,585	13,057,890	0.0%
T. Rowe Price Investment Management, Inc.	163,569	8,519,192	0.11%
Temasek Holdings (Private) Ltd	134,649	7,012,974	0.44%
STATE STREET CORP	120,422	6,272,001	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	118,040	6,147,957	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	117,507	6,120,160	0.01%
FMR LLC	87,847	4,575,374	0.0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	85,100	4,432,314	0.02%
GOLDMAN SACHS GROUP INC	84,619	4,407,255	0.01%
NORGES BANK	84,524	5,119,622	0.01%
BAKER BROS. ADVISORS LP	71,648	3,731,695	0.41%
GEODE CAPITAL MANAGEMENT, LLC	71,575	3,727,114	0.0%
Holocene Advisors, LP	61,352	3,195,429	0.15%
DIMENSIONAL FUND ADVISORS LP	51,686	2,692,175	0.01%
UBS Group AG	49,369	2,571,344	0.01%
Pictet Asset Management Holding SA	48,439	2,558,865	0.05%
Capital Research Global Investors	48,280	2,514,588	0.01%
ALLIANCEBERNSTEIN L.P.	47,773	2,893,618	0.02%
PRICE T ROWE ASSOCIATES INC /MD/	47,313	2,464,146	0.01%
Fisher Asset Management, LLC	46,788	2,436,895	0.02%
Crestline Management, L.P.	42,446	2,210,732	91.74%
Alyeska Investment Group, L.P.	37,269	1,941,123	0.11%
Lynx1 Capital Management LP	36,101	1,880,303	5.71%